Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
source: pixabay.com

Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know

According to a story from LocalHealthGuide, COVID-19 has continued to spread through the US and the lackluster government response suggests that it isn't going to be contained any time soon.…

Continue Reading Coronavirus/COVID-19: What Cancer Patients, Caregivers, and Survivors Need to Know
A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
source: pixabay.com

A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement

  A recent article in ANCA Vasculitis News highlighted a Chinese study of ANCA-associated vasculitis (AAV), a group of autoimmune diseases. An earlier Chinese study suggested that the risk of…

Continue Reading A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
New Research Finds That Chemotherapy After Rare Kidney Cancer Surgery Reduces Chance of Relapse
source: pixabay.com

New Research Finds That Chemotherapy After Rare Kidney Cancer Surgery Reduces Chance of Relapse

  A recent study has found that undergoing chemotherapy after having surgery for a rare kidney cancer reduces the chance of cancer relapse by 50%. The recent study was published…

Continue Reading New Research Finds That Chemotherapy After Rare Kidney Cancer Surgery Reduces Chance of Relapse
Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study
source: pixabay.com

Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study

By Jodee Redmond from In The Cloud Copy The results of a case study have found that dantrolene can be used to treat involuntary muscle contractions (dystonia) in children with…

Continue Reading Dantrolene Effective for Muscle Problems in AADC Deficiency Children: Case Study
Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
source: pixabay.com

Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment

According to a story from businesswire.com, the Bristol Myers Squibb Company recently released the topline results from its phase 3 clinical trial. This study was testing a combination treatment consisting…

Continue Reading Trial Testing Combination Treatment for Untreated Multiple Myeloma Ends in Disappointment
When Her Son Was Diagnosed with MFDM, She Couldn’t Find A Community. So She Helped Build One.
source: pixabay.com

When Her Son Was Diagnosed with MFDM, She Couldn’t Find A Community. So She Helped Build One.

As originally reported in the Cincinnati Children's, Brittney writes how she came into the world of rare diseases when her and her husband Michael decided to adopt a baby who…

Continue Reading When Her Son Was Diagnosed with MFDM, She Couldn’t Find A Community. So She Helped Build One.
Antiphospholipid Syndrome (APS): Young Women are Five Times More Likely Than Men to Have This Rare Disease
source: pixabay.com

Antiphospholipid Syndrome (APS): Young Women are Five Times More Likely Than Men to Have This Rare Disease

According to a recent article in Healio, the National Institute of Health states that one-third of strokes occurring for the first time to people under fifty can be linked to…

Continue Reading Antiphospholipid Syndrome (APS): Young Women are Five Times More Likely Than Men to Have This Rare Disease
Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders
source: pixabay.com

Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders

  According to an article in BioPortfolio, Magenta Therapeutics, a biotechnology company based in Cambridge, Mass., recently announced updates to its Phase II trial of MGTA-456 for the treatment of…

Continue Reading Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders